Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5024
Source ID: NCT00568984
Associated Drug: Repaglinide
Title: Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: repaglinide|DRUG: metformin|DRUG: glicazide
Outcome Measures: Primary: HbA1c, after 16 weeks of treatment | Secondary: Glucose profiles|Quality of life assessment|Treatment satisfaction|Hypoglycaemic events|Adverse events
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 324
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2002-11-21
Completion Date: 2003-11-10
Results First Posted:
Last Update Posted: 2017-02-20
Locations: Novo Nordisk Investigational Site, Beijing, Beijing, 100034, China|Novo Nordisk Investigational Site, Beijing, Beijing, 100044, China|Novo Nordisk Investigational Site, Beijing, Beijing, 100730, China|Novo Nordisk Investigational Site, Tianjin, Tianjin, 300052, China|Novo Nordisk Investigational Site, Cheras, 56000, Malaysia|Novo Nordisk Investigational Site, Ipoh, 30450, Malaysia|Novo Nordisk Investigational Site, Kota Bharu, Kelantan, 16150, Malaysia|Novo Nordisk Investigational Site, Cebu City, 6000, Philippines|Novo Nordisk Investigational Site, Manila, 1003, Philippines|Novo Nordisk Investigational Site, Marikina City, 1800, Philippines|Novo Nordisk Investigational Site, Pampanga, 2000, Philippines|Novo Nordisk Investigational Site, Quezon City, 1100, Philippines|Novo Nordisk Investigational Site, Quezon, 4301, Philippines|Novo Nordisk Investigational Site, Bangkok, 10300, Thailand|Novo Nordisk Investigational Site, Bangkok, 10330, Thailand
URL: https://clinicaltrials.gov/show/NCT00568984

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D262 Repaglinide small molecule DB00912 Details
D179 Niacin small molecule DB00627 Details
D089 Metformin small molecule DB00331 Details